Stock listing
Frankfurt:A8D AB Science SA Aktie
German listing (Frankfurt) of AB Science SA · home listing Euronext:AB
Follow AB Science SA into a list and get an email when it puts out news.
Share price · FWB:A8D
€0.545 EUR +0.018 (+3.4%)
Close on Oct 30, 2026
- Day range
- €0.545 – €0.545 EUROct 30, 2026
- Market cap
- €52.61M EURAt the close on Oct 30, 2026 · price × 96.53M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:AB · Home | €0.541 EUR | -0.007 (-1.3%) | 84,023 | €0.544 | €0.547 | €0.537 | €0.548 | Close on Oct 30, 2026 |
| LSE:0Q77 | €0.53 EUR | -0.022 (-4.0%) | 62 | €0.533 | €0.533 | €0.53 | €0.552 | Close on Oct 27, 2026 |
| Frankfurt:A8D | €0.545 EUR | +0.018 (+3.4%) | — | €0.545 | €0.545 | €0.545 | €0.527 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:A8D
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 12, 2026
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6: 00 p.m. to 7: 30 p.m.
Latest deck · January 2026
Investor Presentation (January 2026)
Investor deck · 33 slides
Latest news
Financings
Private placement of new ordinary shares with share warrants attached (ABSA)
Aug 10, 2026 · US$16.4M
Closed: €14.2M raised · €0.61 a share · 1 warrant at €1 for 60 months
Buyers: Existing long-term investor (EUR 12 million); Stéphane Ledermann
Insiders: The CEO, Stéphane Ledermann, also contributed to the financing
Use of proceeds: Fund R&D programs, mainly AB8939 in acute myeloid leukemia, masitinib in ALS, and nearer-term value-creation projects
Decks
Investor Presentation (January 2026)
Investor deck · 33 slides · January 2026
Investor Presentation (March 2025)
Investor deck · 59 slides · March 2025
Corporate Update (December 2024)
Corporate update · 35 slides · December 2024
Investor Presentation (July 2024)
Investor deck · 46 slides · July 2024
AB Science SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 51 in all · newest Oct 12, 2026 · oldest 2025
- Decks
- 11 decks · latest January 2026
Where AB Science SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:AB · Home listing | Euronext | France | EUR |
| LSE:0Q77 | LSE | United Kingdom | EUR |
| LS Exchange:A1CXBG | LS Exchange | Germany | EUR |
| OTC:ABSCF | OTC | United States | USD |
| Lang & Schwarz:A1CXBG | Lang & Schwarz | Germany | EUR |
| gettex:A8D | gettex | Germany | EUR |
| Aquis:ABP | Aquis | United Kingdom | EUR |
| Turquoise:ABP | Turquoise | United Kingdom | EUR |
| Aquis:ABP | Aquis | United Kingdom | EUR |
| Dusseldorf:A8D | Dusseldorf | Germany | EUR |
| Frankfurt:A8D · This page | Frankfurt | Germany | EUR |
| Hamburg:A8D | Hamburg | Germany | EUR |
| Munich:A8D | Munich | Germany | EUR |
| Stuttgart:A8D | Stuttgart | Germany | EUR |
| Tradegate:A8D | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about AB Science SA.